These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 32412077)

  • 1. Utilization of the Cancer Medications Enquiry Database (CanMED)-National Drug Codes (NDC): Assessment of Systemic Breast Cancer Treatment Patterns.
    Rivera DR; Grothen A; Ohm B; McNeel TS; Brennan S; Lam CJK; Penberthy L; Enewold L; Petkov VI
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):46-52. PubMed ID: 32412077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Utility of the Observational Research in Oncology Toolbox: Cancer Medications Enquiry Database-Healthcare Common Procedure Coding System (HCPCS).
    Rivera DR; Lam CJK; Enewold L; Petkov VI; Tran Q; Brennan S; Dickie L; McNeel TS; Noone AM; Ohm B; White DP; Warren JL; Mariotto AB; Penberthy L
    J Natl Cancer Inst Monogr; 2020 May; 2020(55):39-45. PubMed ID: 32412072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Comparison of Newly Diagnosed Invasive Breast Patient Cohorts in Genomics Evidence Neoplasia Information Exchange Biopharma Collaborative (GENIE-BPC) and Other Real-World Databases.
    Liu X; Alipour GH; Shao C; Burcu M; Bortnichak E; Vo T; Yu CL
    Pharmacoepidemiol Drug Saf; 2024 Aug; 33(8):e5851. PubMed ID: 39090803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.
    Zhang J; Haynes K; Mendelsohn AB; Marshall J; Barr CE; McDermott C; Brown J; Kline A; Kenney J; King KJ; Holmes C; Yeung K; Barron J; Yun H; Lockhart CM
    Pharmacoepidemiol Drug Saf; 2020 Jul; 29(7):778-785. PubMed ID: 31802568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the SEER-Medicare data to identify chemotherapy use.
    Warren JL; Harlan LC; Fahey A; Virnig BA; Freeman JL; Klabunde CN; Cooper GS; Knopf KB
    Med Care; 2002 Aug; 40(8 Suppl):IV-55-61. PubMed ID: 12187169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of three algorithms to identify incident breast cancer in Medicare claims data.
    Gold HT; Do HT
    Health Serv Res; 2007 Oct; 42(5):2056-69. PubMed ID: 17850533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER-Medicare Database.
    Lin CC; Virgo KS; Robbins AS; Jemal A; Ward EM
    Ann Surg Oncol; 2016 Dec; 23(13):4139-4148. PubMed ID: 27535406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Safety of Off-Label Use of Chemotherapeutic Agents in Older Patients With Breast Cancer: Estimates From SEER-Medicare Data.
    Eaton AA; Sima CS; Panageas KS
    J Natl Compr Canc Netw; 2016 Jan; 14(1):57-65. PubMed ID: 26733555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data.
    Du X; Goodwin JS
    J Clin Oncol; 2001 Mar; 19(5):1455-61. PubMed ID: 11230491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women.
    Lairson DR; Parikh RC; Cormier JN; Chan W; Du XL
    Value Health; 2015 Dec; 18(8):1070-8. PubMed ID: 26686793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
    Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
    Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An algorithm for the use of Medicare claims data to identify women with incident breast cancer.
    Nattinger AB; Laud PW; Bajorunaite R; Sparapani RA; Freeman JL
    Health Serv Res; 2004 Dec; 39(6 Pt 1):1733-49. PubMed ID: 15533184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of Using ICD-9-CM and ICD-10-CM Codes for Soft-Tissue Sarcoma in Databases for Health Services Research.
    Hess LM; Zhu YE; Sugihara T; Fang Y; Collins N; Nicol S
    Perspect Health Inf Manag; 2019; 16(Spring):1a. PubMed ID: 31019431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
    Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
    Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of Medicare claims data for measuring cancer stage.
    Cooper GS; Yuan Z; Stange KC; Amini SB; Dennis LK; Rimm AA
    Med Care; 1999 Jul; 37(7):706-11. PubMed ID: 10424641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of treatment of early-stage breast cancer among Nurses' Health Study participants and other Medicare beneficiaries.
    Austin AM; Kapadia NS; Brooks GA; Onega TL; Eliassen AH; Tamimi RM; Holmes M; Wang Q; Grodstein F; Tosteson ANA
    Breast Cancer Res Treat; 2019 Apr; 174(3):759-767. PubMed ID: 30607634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying tests related to breast cancer care in claims data.
    Franc BL; Thombley R; Luo Y; Boscardin WJ; Rugo HS; Seidenwurm D; Dudley RA
    Breast J; 2020 Jun; 26(6):1227-1230. PubMed ID: 31736191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for cancer related health services research using a linked Medicare-tumor registry database.
    Potosky AL; Riley GF; Lubitz JD; Mentnech RM; Kessler LG
    Med Care; 1993 Aug; 31(8):732-48. PubMed ID: 8336512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.